Target intelligence / Profile preview

Proximal tubular damage (PTD)

Target
PTD
Molecular classification
Other
01

Overview

Proximal tubular damage (PTD) refers to the structural or functional impairment of the proximal convoluted tubules in the kidney. These segments are vital for the reabsorption of the vast majority of filtered solutes, including glucose, amino acids, and electrolytes. PTD is a common pathological hallmark of acute kidney injury (AKI) and is frequently induced by ischemia or nephrotoxic agents such as cisplatin, aminoglycosides, and tenofovir. While it represents a critical clinical endpoint and a major safety concern in drug development (nephrotoxicity), it is a physiological state or pathological outcome rather than a specific molecular target like a receptor or enzyme. Therapeutic strategies typically focus on preventing this damage by targeting underlying inflammatory or oxidative pathways rather than the 'damage' itself.

Other names
Proximal tubulopathyAcute tubular injuryProximal renal tubular damageRenal tubular injuryTubular necrosis (proximal)
02

Mechanism of action

Not applicable as this is a pathological state rather than a molecular target.

03

Biological functions

Solute reabsorptionWater homeostasisAcid-base balanceElectrolyte transportBicarbonate reclamationMetabolic waste excretion
04

Disease associations

Acute kidney injuryChronic kidney diseaseFanconi syndromeToxic nephropathyInterstitial nephritis
05

Safety considerations

NephrotoxicityIrreversible renal failureElectrolyte imbalanceMetabolic acidosisDrug-induced kidney injury (DIKI)
06

Biomarkers

Kidney injury molecule-1 (KIM-1)Neutrophil gelatinase-associated lipocalin (NGAL)Beta-2 microglobulinN-acetyl-beta-D-glucosaminidase (NAG)Alpha-1 microglobulinCystatin C

Beyond the preview

Go deeper on Proximal tubular damage (PTD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proximal tubular damage (PTD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call